Recent Company News

• 11:02 PM ET Jan 09, 2026
  

  FDA notifies flu vaccine manufacturers of safety label changes for Febrile Seizure

• 09:04 AM ET Jan 09, 2026
  

  Diamyd Medical 's lead immunotherapy for type 1 diabetes receives global non-proprietary name retogatein (SEK 12.06, +0.22)

• 08:55 AM ET Jan 07, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 02:59 AM ET Jan 07, 2026
  

  StreetAccount Summary - European pre-market trading update

• 06:04 PM ET Jan 06, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 04:15 PM ET Jan 06, 2026
  

  Shares of Ventyx Biosciences continue higher in after-hours

• 12:02 PM ET Jan 06, 2026
  

  Barclays upgrades BAYN.GR, NOVN.SW, ROG.SW; downgrades BIM.FP, DIA.IM, GSK.LN, others

• 03:14 PM ET Jan 05, 2026
  

  CDC acts on Presidential Memorandum to update childhood Immunization schedule

• 02:19 PM ET Jan 05, 2026
  

  FDA issues press release confirming pediatric label expansion for Cablivi (€81.19, 0.00)

• 03:51 AM ET Jan 05, 2026
  

  Sanofi KK to transfer Japan sales of Jevtana to Otsuka Holdings's Taiho Pharmaceutical, effective 1-Apr; terms undisclosed (¥9049.0000, 0)